Targeting hypoxic cancer stem cells (CSCs) with Doxycycline: Implications for optimizing anti-angiogenic therapy.
about
Drug Resistance Driven by Cancer Stem Cells and Their Niche.G Protein-Coupled Receptors at the Crossroad between Physiologic and Pathologic Angiogenesis: Old Paradigms and Emerging Concepts.Exploiting mitochondrial targeting signal(s), TPP and bis-TPP, for eradicating cancer stem cells (CSCs).Cancer stem cells (CSCs): metabolic strategies for their identification and eradication.A mitochondrial based oncology platform for targeting cancer stem cells (CSCs): MITO-ONC-RX
P2860
Targeting hypoxic cancer stem cells (CSCs) with Doxycycline: Implications for optimizing anti-angiogenic therapy.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Targeting hypoxic cancer stem ...... izing anti-angiogenic therapy.
@en
type
label
Targeting hypoxic cancer stem ...... izing anti-angiogenic therapy.
@en
prefLabel
Targeting hypoxic cancer stem ...... izing anti-angiogenic therapy.
@en
P2860
P50
P356
P1433
P1476
Targeting hypoxic cancer stem ...... izing anti-angiogenic therapy.
@en
P2093
Ernestina Marianna De Francesco
Marcello Maggiolini
P2860
P304
56126-56142
P356
10.18632/ONCOTARGET.18445
P407
P577
2017-06-12T00:00:00Z